跳至主要内容
临床试验/EUCTR2007-001916-22-GB
EUCTR2007-001916-22-GB进行中(未招募)1 期

Study to assess the optimum dose of intravenous adenosine in the assessment of fractional flow reserve - Pressure Wire Study

Central Manchester and Manchester Children's Hospital University NHS Trust0 个研究点目标入组 0 人开始时间: 2007年7月31日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Any patient listed for pressure wire study of a moderate coronary artery lesion
  • Any patient attending for coronary angiography +/- proceed who is found to have a moderate lesion considered to require pressure wire assessment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any patient who is unable or unwilling to give full informed consent.
  • Patients with a contraindication to the administration of adenosine:
  • Patients with a history of allergy or previous adverse reaction to administration of adenosine
  • Second or third degree AV block, sick sinus syndrome (except in patients with a permanent pacemaker)
  • Long QT syndrome
  • Wolff Parkinson White Syndrome
  • Severe hypotension (SBP <90)
  • Unstable angina not successfully stabilised with medical therapy
  • Decompensated heart failure
  • Severe asthma
  • Patients taking dipyridamole
  • Patients taking theophylline / aminophylline therapy

研究者

发起方
Central Manchester and Manchester Children's Hospital University NHS Trust

相似试验